Finance

Lists
Why is SBS up ३.०१%?
Dive Deeper
SBS:FRA
Stratec SE
€ २२.२५
+३.०१%
(+०.६५) 1D
अक्टोबर १२, ०८:०२:१० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€ २२.२५
High
€ २२.२५
Low
€ २२.२५
Mkt. cap
२८.२१ करोड
Avg. vol.
५१.००
Volume
०.००
Dividend
२.७०%
Quarterly dividend
€ ०.१५
Ex-dividend date
२०२६ जुन २४
52-wk high
€ ३०.०५
52-wk low
€ १६.३८
EPS
-€ ०.०३
Shares outstanding
१.२० करोड
No. of employees
१ हजार
Open
€ २२.२५
High
€ २२.२५
Low
€ २२.२५
Mkt. cap
२८.२१ करोड
Avg. vol.
५१.००
Volume
०.००
Dividend
२.७०%
Quarterly dividend
€ ०.१५
Ex-dividend date
२०२६ जुन २४
52-wk high
€ ३०.०५
52-wk low
€ १६.३८
EPS
-€ ०.०३
Shares outstanding
१.२० करोड
No. of employees
१ हजार
News stories
From web sources and news partners
StockStory
StockStory
·
१९ मिनेट पहिले
2 S&P 500 Stocks to Own for Decades and 1 We Find Risky
Bloomberg.com
Bloomberg.com
·
३४ मिनेट पहिले
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees१.३८ हजार
Founded१९७९
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५.७० करोड
७.५३ करोड
५.३४ करोड
५.९१ करोड
Cost of goods sold
४.३७ करोड
५.६३ करोड
४.३२ करोड
४.३९ करोड
Cost of revenue
४.३७ करोड
५.६३ करोड
४.३२ करोड
४.३९ करोड
Research and development expenses
१५.८७ लाख
२७.७६ लाख
१७.१८ लाख
१४.८७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८४.७० लाख
१.०८ करोड
८८.२२ लाख
९६.३६ लाख
Operating expense
९७.८३ लाख
१.१२ करोड
१.०३ करोड
९६.६५ लाख
Total operating expenses
५.३५ करोड
६.७५ करोड
५.३५ करोड
५.३५ करोड
Operating income
३५.१९ लाख
७७.७६ लाख
-१.०४ लाख
५५.७४ लाख
Other non operating income
-१.१७ लाख
२.१९ लाख
-६५.०० हजार
६१.०० हजार
EBT including unusual items
२३.७९ लाख
-८.२६ लाख
-११.५६ लाख
५४.३० लाख
EBT excluding unusual items
२३.७९ लाख
५५.४९ लाख
-११.५६ लाख
५४.३० लाख
Income tax expense
८.७८ लाख
३५.१९ लाख
५.५७ लाख
१२.६८ लाख
Effective tax rate
३६.९१%
-४२६.०३%
-४८.१८%
२३.३५%
Other operating expenses
-२.७४ लाख
-२४.०८ लाख
-२.३५ लाख
-१४.५८ लाख
Net income
१५.०१ लाख
-४३.४५ लाख
-१७.१३ लाख
४१.६२ लाख
Net profit margin
२.६३%
-५.७७%
-३.२१%
७.०४%
Earnings per share
-
-
-
-
Interest and investment income
३३.०० हजार
८.०० हजार
३४.०० हजार
५५.०० हजार
Interest expense
-१०.५६ लाख
-९.५५ लाख
-१०.२१ लाख
-२.६० लाख
Net interest expenses
-१०.२३ लाख
-९.४७ लाख
-९.८७ लाख
-२.०५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
८०.३९ लाख
१.०७ करोड
४४.५२ लाख
१.०० करोड
Gain or loss from assets sale
१३.०० हजार
३.०० हजार
-९४.०० हजार
-९.०० हजार
AI content may include mistakes. Learn more
Google एपहरू